Achilles Therapeutics (ACHL) Institutional Ownership

$0.83

-0.01 (-1.19%)

(As of 07/26/2024 ET)

Current Institutional Ownership Percentage: 56.38%
Number of Institutional Buyers (last 12 months): 5
Total Institutional Inflows (last 12 months): $6.11M

Number of Institutional Sellers (last 12 months): 3
Total Institutional Outflows (last 12 months): $3.02M

Get ACHL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACHL Institutional Buying and Selling by Quarter

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Achilles Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/20/2024	Virtu Financial LLC	20,947	$26K	0.0%	-47.1%	0.051%
5/17/2024	Artal Group S.A.	755,375	$944K	0.0%	-66.5%	1.894%
5/17/2024	Ikarian Capital LLC	1,443,181	$1.80M	0.2%	N/A	3.619%
5/15/2024	Baker BROS. Advisors LP	1,208,775	$1.51M	0.0%	-42.5%	3.031%
5/14/2024	StemPoint Capital LP	1,385,750	$1.73M	0.5%	N/A	3.475%
5/10/2024	Acadian Asset Management LLC	280,929	$350K	0.0%	N/A	0.704%
Get the Latest News and Ratings for ACHL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
3/7/2024	Fcpm Iii Services B.V.	2,390,050	$2.13M	0.6%	N/A	5.861%
2/14/2024	Vestal Point Capital LP	108,083	$96K	0.0%	N/A	0.265%
5/12/2023	Forefront Analytics LLC	75,625	$72K	0.0%	+147.7%	0.185%
2/14/2023	RA Capital Management L.P.	1,607,834	$1.45M	0.0%	-67.9%	4.107%
11/14/2022	Point72 Asset Management L.P.	2,107,595	$4.76M	0.0%	+18.6%	5.383%
11/14/2022	Forefront Analytics LLC	32,200	$72K	0.0%	N/A	0.082%
8/15/2022	Point72 Asset Management L.P.	1,776,744	$4.48M	0.0%	+18.4%	4.538%
8/15/2022	Kettle Hill Capital Management LLC	242,978	$612K	0.2%	N/A	0.621%
2/15/2022	Sender Co & Partners Inc.	27,690	$139K	0.1%	N/A	0.068%
2/14/2022	Point72 Asset Management L.P.	1,000,000	$5.01M	0.0%	+100.0%	2.463%
2/11/2022	Syncona Portfolio Ltd	11,086,909	$55.55M	53.1%	N/A	27.306%
11/15/2021	Point72 Asset Management L.P.	500,000	$3.90M	0.0%	N/A	1.231%
11/15/2021	Sphera Funds Management LTD.	242,500	$1.89M	0.2%	-17.0%	0.597%
11/15/2021	AXA S.A.	279,454	$2.18M	0.0%	+3.8%	0.688%
11/15/2021	Farallon Capital Management LLC	450,000	$3.51M	0.0%	-54.8%	1.108%
11/12/2021	Affinity Asset Advisors LLC	100,000	$779K	0.2%	+25.0%	0.246%
8/17/2021	Woodline Partners LP	77,386	$758K	0.0%	-67.6%	0.191%
8/17/2021	Sphera Funds Management LTD.	292,194	$2.86M	0.2%	-2.6%	0.719%
8/17/2021	Millennium Management LLC	196,144	$1.92M	0.0%	-3.3%	0.483%
8/16/2021	RA Capital Management L.P.	5,014,687	$49.09M	0.8%	+261.1%	12.345%
8/16/2021	Pinz Capital Management LP	16,423	$161K	0.0%	+164.8%	0.040%
8/16/2021	Macquarie Group Ltd.	40,402	$396K	0.0%	-26.9%	0.099%
8/13/2021	Affinity Asset Advisors LLC	80,000	$783K	0.3%	+220.0%	0.197%
8/13/2021	AXA S.A.	269,135	$2.64M	0.0%	N/A	0.663%
8/12/2021	JPMorgan Chase & Co.	49,405	$484K	0.0%	-92.1%	0.122%
8/12/2021	Monashee Investment Management LLC	64,697	$633K	0.1%	-48.2%	0.159%
8/6/2021	Sei Investments Co.	16,220	$159K	0.0%	N/A	0.040%
8/3/2021	Peregrine Capital Management LLC	225,669	$2.21M	0.0%	-30.0%	0.556%
6/10/2021	Perceptive Advisors LLC	755,375	$12.50M	0.2%	N/A	1.860%
5/19/2021	Squarepoint Ops LLC	28,000	$463K	0.0%	N/A	0.069%
5/18/2021	Baker BROS. Advisors LP	2,591,366	$42.89M	0.2%	N/A	6.379%
5/18/2021	Millennium Management LLC	202,785	$3.36M	0.0%	N/A	0.499%
5/18/2021	RA Capital Management L.P.	1,388,888	$22.99M	0.3%	N/A	3.419%
5/18/2021	Orbimed Advisors LLC	1,584,845	$26.23M	0.2%	N/A	3.901%
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here
5/18/2021	Redmile Group LLC	2,088,089	$34.56M	0.5%	N/A	5.140%
5/18/2021	Alyeska Investment Group L.P.	32,230	$533K	0.0%	N/A	0.079%
5/18/2021	Boxer Capital LLC	1,536,208	$25.42M	0.9%	N/A	3.782%
5/18/2021	Citadel Advisors LLC	39,253	$650K	0.0%	N/A	0.097%
5/17/2021	Deerfield Management Company L.P. Series C	800,000	$13.24M	0.3%	N/A	1.969%
5/17/2021	Perceptive Advisors LLC	755,375	$12.50M	0.2%	N/A	1.860%
5/17/2021	Woodline Partners LP	238,822	$3.95M	0.1%	N/A	0.588%
5/17/2021	Caas Capital Management LP	50,000	$828K	0.0%	N/A	0.123%
5/17/2021	Pinz Capital Management LP	6,203	$103K	0.0%	N/A	0.015%
5/17/2021	Sphera Funds Management LTD.	300,000	$4.97M	0.4%	N/A	0.739%
5/14/2021	Monashee Investment Management LLC	125,000	$2.07M	0.3%	N/A	0.308%
5/12/2021	Pura Vida Investments LLC	103,026	$1.71M	0.0%	N/A	0.254%
5/12/2021	JPMorgan Chase & Co.	625,750	$10.36M	0.0%	N/A	1.540%
5/11/2021	Peregrine Capital Management LLC	322,261	$5.33M	0.1%	N/A	0.793%
5/11/2021	Landscape Capital Management L.L.C.	12,540	$208K	0.0%	N/A	0.031%
5/7/2021	BlackRock Inc.	25,000	$413K	0.0%	N/A	0.062%

(Data available from 1/1/2016 forward)

ACHL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACHL shares?: During the previous two years, 12 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were Point72 Asset Management L.P. ($4.76M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), RA Capital Management L.P. ($1.45M), and Artal Group S.A. ($944K).Learn more on ACHL's institutional investors.
What percentage of Achilles Therapeutics stock is owned by institutional investors?: 56.38% of Achilles Therapeutics stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings.
Which institutional investors have been buying Achilles Therapeutics stock?: The following institutional investors have purchased Achilles Therapeutics stock in the last 24 months: Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Point72 Asset Management L.P. ($607.60K), Acadian Asset Management LLC ($280.93K), Kettle Hill Capital Management LLC ($242.98K), and Vestal Point Capital LP ($108.08K).

How much institutional buying is happening at Achilles Therapeutics?: Institutional investors have bought a total of 6,535,866 shares in the last 24 months. This purchase volume represents approximately $8.28M in transactions.
Which Achilles Therapeutics major shareholders have been selling company stock?: The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: RA Capital Management L.P. ($3.41M), Artal Group S.A. ($1.50M), Baker BROS. Advisors LP ($894.02K), and Virtu Financial LLC ($18.65K).
How much institutional selling is happening at Achilles Therapeutics?: Institutional investors have sold a total of 5,819,516 shares in the last 24 months. This volume of shares sold represents approximately $6.08M in transactions.